MorphoSys Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

MorphoSys has a total shareholder equity of €-334.7M and total debt of €1.7B, which brings its debt-to-equity ratio to -518.3%. Its total assets and total liabilities are €1.7B and €2.0B respectively.

Anahtar bilgiler

-518.3%

Borç/özkaynak oranı

€1.73b

Borç

Faiz karşılama oranın/a
Nakit€512.31m
Eşitlik-€334.72m
Toplam yükümlülükler€2.04b
Toplam varlıklar€1.71b

Son finansal sağlık güncellemeleri

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MOR has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: MOR has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MOR has negative shareholder equity, which is a more serious situation than a high debt level.

Borcun Azaltılması: MOR's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: MOR has sufficient cash runway for more than a year based on its current free cash flow.

Tahmini Nakit Akışı: MOR has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 33.9% each year.


Sağlıklı şirketleri keşfedin